FONT-SIZE Plus   Neg

Mylan Pharma Launches Escitalopram Tablets USP, 5 Mg, 10 Mg And 20 Mg

Mylan Inc. (MYL) said its subsidiary Mylan Pharmaceuticals Inc. has launched Escitalopram Tablets USP, 5 mg, 10 mg and 20 mg, the first equivalent product to Forest Laboratories' (FRX) Lexapro.

Lexapro is used for acute and maintenance treatment of major depressive disorder and acute treatment of generalized anxiety disorder.

Mylan will market this product exclusively until the expiration of the pediatric exclusivity on the compound patent, as per the settlement agreement between Mylan's Alphapharm subsidiary and Forest Laboratories Inc.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of Orange SA (ORAN) were gaining around 5 percent in the morning trading in Paris after the French telecom major reported higher restated EBITDA, a key earnings metric, in its third quarter with slightly higher sales. This was despite weakness in its domestic market. Further, the company maintained its fiscal 2016 forecast of restated EBITDA to be greater than last year, on a comparable bas Swiss drug giant Novartis AG reported Tuesday higher net profit in its third quarter, while sales were weak due to generic competition and pricing. Core earnings per share topped analysts' estimates, but sales missed their view. For fiscal 2016, the company continues to expect Core operating income to be broadly in line or decline low-single digit, and net sales to be broadly in line.. Social media site Twitter Inc., which is facing an uncertain future, is planning to cut around 8 percent of its total workforce, Bloomberg reported Monday citing people familiar with the matter. The company, which is trying cost control amid slowing sales growth, may announce the job cut of about 300 people as soon as this week.
comments powered by Disqus
Follow RTT